ALLOX

Allostery

Allostery develops multimodal artificial intelligence foundation models to design protein functions and identify regulatory sites for researchers and pharmaceutical developers.

UbiquiTx

This company develops a programmable protein modulation platform using artificial intelligence to create targeted therapies for pharmaceutical businesses and patients with complex diseases.

DreamFold

This company develops generative AI models for protein design to discover new therapeutic drugs for pharmaceutical researchers and clinicians.

Allorion

This biotechnology company develops small-molecule drugs for patients with cancer and autoimmune diseases using its proprietary drug discovery platforms.

MendelFOLD

This company develops computational protein modelling tools to help pharmaceutical teams and researchers identify drug binding sites and design new medical treatments.

Interax

This company develops a computational pharmacology platform to design and optimise drug candidates targeting G-protein-coupled receptors for biopharmaceutical partners.

ProtOS

This company develops artificial intelligence models to design de-novo proteins for the degradation of undruggable targets for the pharmaceutical and medical biotechnology industries.

Axiom Bio

This company develops artificial intelligence models that predict drug toxicity to help pharmaceutical researchers identify safety risks early in the development process.